Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03262038 · ClinicalTrials.gov registry record · Phase 4
Does IV Ondansetron Prevent Pruritus After Intrathecal Morphine in Pediatric Patients?
A Phase 4 study, sponsored by University of Michigan.
- Terminated
- Registry status
- Phase 4
- Development phase
- 46
- Enrollment target
NCT03262038 is a Phase 4 study that was terminated before completion, run by University of Michigan. The registered enrollment target is 46 participants.
The verdict
NCT03262038, a Phase 4 study, was terminated before completion, sponsored by University of Michigan.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 46 participants
- Enrollment target
Study Summary
This is a prospective randomized, double-blind, placebo-controlled study to compare the incidence and intensity of ITM-induced pruritus and nausea/vomiting using pre-emptive IV ondansetron, followed by scheduled Around The Clock (ATC) ondansetron vs. our control group, where pruritus and PONV are treated with PRN only medications.
Interventions
- DRUG Ondansetron
- DRUG Placebo Comparator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2017-12-07 |
| Est. Completion | 2019-08-20 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03262038
The ClinicalTrials.gov registry entry for NCT03262038 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ondansetron is the first listed.
NCT03262038 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03262038 about?
NCT03262038 is a clinical study titled "Does IV Ondansetron Prevent Pruritus After Intrathecal Morphine in Pediatric Patients?". This is a prospective randomized, double-blind, placebo-controlled study to compare the incidence and intensity of ITM-induced pruritus and nausea/vomiting using pre-emptive IV ondansetron, followed by scheduled Around The Clock (ATC) ondansetron vs. our control group, where pruritus and PONV are tr...
What is the current status of trial NCT03262038?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 46 participants. The study started on 2017-12-07. Estimated completion is 2019-08-20.
What interventions are being tested in trial NCT03262038?
The interventions under investigation include: Ondansetron (DRUG), Placebo Comparator (DRUG).
Who is sponsoring clinical trial NCT03262038?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.